In 2025, Emily C. Fraschetti and a team from York University studied 30 healthy young males in a 12-week trial. They did resistance and plyometric exercises twice weekly, with half consuming Greek yogurt (20g protein) and half an isoenergy carb pudding post-workout. They measured inflammation markers like IL-6, TNF-α, and CRP in blood at start, 6 weeks, and end.

In 2025, Zhenqi Liu and team from the University of Virginia reviewed studies on GLP-1 drugs like Ozempic, focusing on their impact on cardiorespiratory fitness (CRF), a key predictor of heart health and longevity. While these drugs drive significant weight loss, they also reduce fat-free mass (25-40% of total weight lost), including vital muscle, raising concerns about long-term health.